Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin add-on to basal insulin in elderly patients with type 2 diabetes mellitus
2014-000904-88Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Trajenta + basal insulin with Placebo + basal insulin (2 arms). Primary endpoint: Change from baseline in glycated haemoglobin after 24 weeks. Started Jul 2014; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-000904-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000904-88.